Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | MAP3K12 |
| Upstream (Parents) |
|---|
| (<<) ACTA2 → MAP3K12 |
| (<<) CASP9 → MAP3K12 |
| (<<) CLEC2B → MAP3K12 |
| (<<) DDX21 → MAP3K12 |
| (<<) GNAQ → MAP3K12 |
| (<<) GNB1 → MAP3K12 |
| (<<) GPX4 → MAP3K12 |
| (<<) GRPEL1 → MAP3K12 |
| (<<) HIPK1 → MAP3K12 |
| (<<) KCTD12 → MAP3K12 |
| (<<) MAN2A2 → MAP3K12 |
| (<<) MAP2K1 → MAP3K12 |
| (<<) MAP2K3 → MAP3K12 |
| (<<) MAP3K4 → MAP3K12 |
| (<<) PIK3R5 → MAP3K12 |
| (<<) PRKCQ → MAP3K12 |
| (<<) PTRF → MAP3K12 |
| (<<) RAB5B → MAP3K12 |
| (<<) RAB5C → MAP3K12 |
| (<<) SPPL2B → MAP3K12 |
| (<<) THRB → MAP3K12 |
| Downstream (Children) |
|---|
| MAP3K12 → ALOX15B (>>) |
| MAP3K12 → ANKRD27 (>>) |
| MAP3K12 → ASNS (>>) |
| MAP3K12 → BCL2 (>>) |
| MAP3K12 → CASP10 (>>) |
| MAP3K12 → CEP170 (>>) |
| MAP3K12 → DMPK (>>) |
| MAP3K12 → DUSP4 (>>) |
| MAP3K12 → EHD1 (>>) |
| MAP3K12 → HMGCS1 (>>) |
| MAP3K12 → KRT75 (>>) |
| MAP3K12 → MAP3K8 (>>) |
| MAP3K12 → MYL6B (>>) |
| MAP3K12 → PDGFB (>>) |
| MAP3K12 → PLA2G4C (>>) |
| MAP3K12 → PODXL (>>) |
| MAP3K12 → PRKAB1 (>>) |
| MAP3K12 → PRKCE (>>) |
| MAP3K12 → RAD51L3 (>>) |
| MAP3K12 → RGS20 (>>) |
| MAP3K12 → RHBDL1 (>>) |
| MAP3K12 → RTN3 (>>) |
| MAP3K12 → SLC5A1 (>>) |
| MAP3K12 → TMEM39B (>>) |
| MAP3K12 → TUBA1A (>>) |
| MAP3K12 → UBE2C (>>) |
